|
|
||||||||
Journal of Lipid Research, Vol 36, 1227-1235, Copyright © 1995 by Lipid Research, Inc.
SH Quarfordt, B Oswald, B Landis, HS Xu, SH Zhang and N Maeda
The in vivo total body cholesterol transport of homozygous apoE- deficient
(-/-) and control (+/+) mice was evaluated by compartmental analysis of
plasma cholesterol decay. Body cholesterol fractional catabolic rates of
chow fed mutants were less (-/-, 0.17 +/- 0.02; +/+, 0.51 +/- 0.06 day-1)
and body cholesterol contents greater (-/-, 68 +/- 5; +/+, 48 +/- 5 mumol)
than controls. The body cholesterol expansion of the chow-fed mutant was
extracellular with at least half in plasma. Cholesterol transport, i.e.,
the mass entering, moving through, and exiting the body each day, was
similar (-/-, 6.9 +/- 0.7; +/+, 8.5 +/- 0.9 mumol/day) for homozygotes and
controls on chow, and both tripled with cholesterol feeding. Differing from
controls, however, mutants had considerable expansions of plasma and body
cholesterol (-/-, 166 +/- 21; +/+, 59 +/- 11 mumol) with increments in
peripheral tissue cholesterol contents. Cholesterol feeding increased
control hepatic cholesterol without a change in plasma, whereas mutants had
large increments in plasma cholesterol with no change in liver. Consistent
with impaired hepatic uptake of cholesterol, mutants had much slower plasma
clearance of lipoprotein cholesterol, as well as slower transfer to
catabolic pools than normals. Treatment of homozygotes with lovastatin
doubled both plasma cholesterol concentration and body cholesterol
transport indicating the importance of apoE-dependent cell cholesterol
transfer in synthetic down-regulation with this agent. These data indicate
that mice lacking apoE have lower affinity hepatic uptake of plasma remnant
cholesterol.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
In vivo cholesterol kinetics in apolipoprotein E-deficient and control mice
Department of Medicine, Durham VA Hospital, NC 27705, USA.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Zadelaar, R. Kleemann, L. Verschuren, J. de Vries-Van der Weij, J. van der Hoorn, H. M. Princen, and T. Kooistra Mouse Models for Atherosclerosis and Pharmaceutical Modifiers Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1706 - 1721. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Mensenkamp, B. Teusink, J. F.W. Baller, H. Wolters, R. Havinga, K. W. van Dijk, L. M. Havekes, and F. Kuipers Mice Expressing Only the Mutant APOE3Leiden Gene Show Impaired VLDL Secretion Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1366 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R Mensenkamp, M. C Jong, H. van Goor, M. J. A. van Luyn, V. Bloks, R. Havinga, P. J. Voshol, M. H. Hofker, K. W. van Dijk, L. M. Havekes, et al. Apolipoprotein E Participates in the Regulation of Very Low Density Lipoprotein-Triglyceride Secretion by the Liver J. Biol. Chem., December 10, 1999; 274(50): 35711 - 35718. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Calleja, M. A. Paris, A. Paul, E. Vilella, J. Joven, A. Jimenez, G. Beltran, M. Uceda, N. Maeda, and J. Osada Low-Cholesterol and High-Fat Diets Reduce Atherosclerotic Lesion Development in ApoE-Knockout Mice Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2368 - 2375. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Sullivan, H. Mezdour, Y. Aratani, C. Knouff, J. Najib, R. L. Reddick, S. H. Quarfordt, and N. Maeda Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis J. Biol. Chem., July 18, 1997; 272(29): 17972 - 17980. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |